Riskpilot← Back to searchSign inGet full accessNESBRUKLINIKKEN AS
ASActiveOrg 985632073Holmquistveien 1, 1394 NesbruPhysiotherapy activities · NACE 8695Est. 20031 employees
Revenue 2024
NOK 3M
+49% vs 2023
EBITDA margin
0.8%
+117% vs 2023
Equity ratio
20.3%
Financial strength
Net profit 2024
NOK 26K
+118% vs 2023
| Revenue | NOK 3M | +49% |
| EBITDA | NOK 25K | +117% |
| Net profit | NOK 26K | +118% |
| Total assets | NOK 264K | +66% |
| Equity | NOK 54K | +95% |
| Employees | 1 | — |
Legal name
NESBRUKLINIKKEN AS
Org number
985632073
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
30. april 2003
Share capital
NOK 120 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Tre styremedlemmer i fellesskap.
Company purpose
Å utvikle fysioterapivirksomhet og andre tilknyttede arbeidsområder. Selskapets strategi skal være langsiktig økning av verdiene, herunder gjennomføring av naturlige ekspansive tiltak innenfor selskapets kjerneområder.
Address
Holmquistveien 1, 1394 Nesbru
Phone
+4766853120
Email
post@nesbrufysio.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 434 | 1 918 | 1 856 | 1 994 | 2 964 |
| Staff expenses | −173 | −290 | −301 | −350 | −506 |
| EBITDA | −10 | 150 | −114 | −147 | 25 |
| Depreciation & amort. | −34 | −39 | −15 | −0 | −0 |
| EBIT | −45 | 111 | −129 | −147 | 25 |
| Net financials | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | −43 | 112 | −128 | −146 | 26 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −43 | 112 | −128 | −146 | 26 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 237 | 352 | 413 | 159 | 264 |
| Equity | 189 | 302 | 174 | 28 | 54 |
| Long-term debt | 0 | 3 | 3 | 0 | 0 |
| Short-term debt | 47 | 47 | 236 | 131 | 211 |
| Total debt | 47 | 50 | 239 | 131 | 211 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20202024
Equity ratio
20.3%
This company
38.2%
Market median
-47% vs market
20202024
Return on equity
48.6%
This company
18.4%
Market median
+164% vs market
20202024
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20202024
Asset turnover
11.22×
This company
1.12×
Market median
+902% vs market
20202024
Debt / equity
3.93×
This company
0.62×
Market median
-534% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2022 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NESBRUKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Krieg | Board of Directors | 0 companies |